Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1999
10/19/1999US5969093 Secreted proteins
10/19/1999US5968982 2,2-Dichloroalkanecarboxylic acids, processes for their production and pharmaceutical agents containing these
10/19/1999US5968978 Antiarrythmia agents, antiischemic agents, inhibit proliferation of cells
10/19/1999US5968963 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
10/19/1999US5968954 Exhibit selective binding affinity for 5-hydroxytryptamine receptors
10/19/1999US5968950 Treatment of hypertriglyceridemia with decreasing apo b secretion for treatment of atheriosclerosis, pancreatitis, obesity or diabetes
10/19/1999US5968924 Benzo-fused lactams promote release of growth hormone
10/19/1999US5968826 Antisense inhibition of integrin α4 expression
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968764 Detecting modulators of glucose transport protein; therapy for diabetes and disorders of insulin resistance, by incubating glucose transport protein with test compound, adding transport protein substrate, monitoring effect
10/19/1999US5968516 Soybean drug and new method of extracting soybean saponins
10/19/1999US5968508 Neutralization of pc-1 glycoprotein; treating diabetes
10/19/1999CA2003524C Treatment of obesity
10/16/1999CA2269049A1 N-acyl and n-aroyl aralkyl amides
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051626A2 Template associated npy y2-receptor agonists
10/14/1999WO1999051608A1 THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
10/14/1999WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES
10/14/1999WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors
10/14/1999WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
10/14/1999WO1999051569A1 Calcilytic compounds
10/14/1999WO1999051564A1 Propanolamine derivatives
10/14/1999WO1999051271A2 Compositions comprising glycol derivatives and alcohols
10/14/1999WO1999051241A1 Calcilytic compounds and method of use
10/14/1999WO1999051225A1 Antidiabetic agents
10/14/1999WO1999043705A8 N-terminally truncated glp-1 derivatives
10/14/1999WO1999043361A8 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
10/14/1999WO1999042089A3 Use of thiadiazolo[4,3-a]pyridine derivatives
10/14/1999WO1999039702A3 Method for regulating size and growth of vascularized normal tissue
10/14/1999WO1999037604A3 Dialkyl ureas as calcitonin mimetics
10/14/1999CA2328607A1 Antidiabetic agents
10/14/1999CA2327279A1 Calcilytic compounds
10/14/1999CA2327188A1 Calcilytic compounds and method of use
10/14/1999CA2326884A1 Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
10/14/1999CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b|indole and 9h-pyrimidino¬4,5-b|indole derivatives:crf1 and npy1 receptors
10/14/1999CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b|pyridine and pyrrolo¬2,3-d|pyrimidine derivatives: modulators of crf1 receptors
10/14/1999CA2326319A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino¬2,3-b|indole and 5,6,7,8-tetrahydro-9h-pyrimidino¬4,5-b|indole derivatives: crf1 specific ligands
10/14/1999CA2326146A1 Template associated npy y2-receptor agonists
10/14/1999CA2325523A1 Prodrugs of phosphorous-containing pharmaceuticals
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0948651A1 Recombinant n-smases and nucleic acids encoding same
10/13/1999EP0948609A2 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
10/13/1999EP0948499A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
10/13/1999EP0948498A1 Sulfonamide compounds having 5-ht receptor activity
10/13/1999EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948494A1 Substituted benzo 1,4]dioxanes as antiobesity agents
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948336A1 Palatable hydroxypropyl methylcellulose ether powder with specified particle size
10/13/1999EP0948327A1 Antidiabetic agents
10/13/1999EP0948320A1 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN
10/13/1999EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999EP0828503A4 Treatment for inhibiting the progression of autoimmune disease
10/13/1999EP0668854B1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
10/13/1999EP0564592B1 Liver enriched transcription factor
10/13/1999CN1231672A Conformationally constrained backbone cyclized somatostatin analogs
10/13/1999CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999CN1231611A Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha'
10/13/1999CN1231605A Use of sibutramine analogues to lower lipid levels
10/13/1999CN1045602C Tetrahydropyrido-indole derivant and medicinal composition and pharmaceutical use thereof
10/13/1999CN1045596C Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
10/12/1999US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999US5965584 Pharmaceutical composition
10/12/1999US5965575 N-aryl piperidine compounds as 5HT1B antagonists
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/12/1999US5965521 Pulsatile delivery of leptin receptor ligands
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965397 Protein factor, cytokines, lymphokines, interferons, and interleukins, and colony stimulating factors; treatment of osteoporosis, stimulating or bone growth, regeneration of nerve and brain tissue, alzheimer/huntington disease's
10/12/1999US5965392 A nucleic acid molecule; treating obesity or anorexia
10/10/1999CA2263059A1 New peptide compounds analogue to glucagon-like-peptide-1 (7-37), their preparation process and the pharmaceutical compositions containing them
10/07/1999WO1999050658A2 Methods and compounds for modulating nuclear receptor activity
10/07/1999WO1999050413A2 THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY
10/07/1999WO1999050403A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999WO1999050268A2 Substituted indolealkanoic acids
10/07/1999WO1999050267A1 Process for producing isooxazolidinedione compound
10/07/1999WO1999050239A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
10/07/1999WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999WO1999049896A1 A drug composition containing sodium pravastatin
10/07/1999WO1999049894A1 Antagonists to growth arrest specific gene 6 to treat insulin-resistant disorders
10/07/1999WO1999049877A2 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
10/07/1999WO1999049870A1 Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
10/07/1999WO1999049734A1 Method of inhibiting immune system destruction of transplanted viable cells
10/07/1999WO1999043310A3 20-hete antagonists and agonists
10/07/1999WO1999037309A9 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation
10/07/1999DE19815411A1 Thermogenesis stimulant comprising moxonidine, useful e.g. for treating hypothermia or promoting weight loss, having no cardiac stimulant side effects
10/07/1999CA2326603A1 A drug composition containing sodium pravastatin
10/07/1999CA2326117A1 Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
10/07/1999CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
10/07/1999CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999CA2324060A1 Methods and compounds for modulating nuclear receptor activity
10/07/1999CA2290363A1 Method of inhibiting immune system destruction of transplanted viable cells
10/06/1999EP0947578A1 Substance with antiobestic and cumulative visceral fat-reducing actions and use thereof
10/06/1999EP0946721A1 Human growth gene and short stature gene region
10/06/1999EP0946587A2 New amide compounds
10/06/1999EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS
10/06/1999EP0946554A1 Fused bicyclic pyrimidine derivatives
10/06/1999EP0946550A1 PREPARATION OF 1S- 1a,2b,3b,4a(S*)]]-4- 7- 1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO 4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
10/06/1999EP0946541A1 Quinolines and their therapeutic use
1 ... 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 ... 1298